Madrigal Pharmaceuticals
Price & Volume
Stats
See moreOpen | $511.84 |
Previous Close | $519.75 |
Day Range | $511.84-$525.70 |
52W Range | $265-$615 |
Market Cap | $11.7B |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $958.4M |
Revenue Growth (YoY) | 210.8% |
Gross Profit (12 Mos) | $902.2M |
Diluted EPS | -$12.85 |
News
See moreYahoo Finance • 2 days ago
Noteworthy Tuesday Option Activity: WSBF, MDGL, NKE
Yahoo Finance • 4 days ago
Notable healthcare headlines for the week: Apellis, Centessa, and UnitedHealth in focus
Yahoo Finance • 13 days ago
Madrigal Pharmaceuticals (MDGL) Surged on Strong Sales of Its Rezdiffra Drug
Yahoo Finance • 19 days ago
This New $193 Million Bet Targets a Biotech With $689 Million in Revenue and a Potential Turnaround Story
About
CEO | Mr. William J. Sibold |
CFO | Ms. Mardi C. Dier |
Address | Four Tower Bridge, West Conshohocken, PA, United States, 19428 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 915 |
